Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Extensive review on breast cancer its etiology, progression, prognostic markers, and treatment
Harshini Swaminathan, K. Saravanamurali, Sangilimuthu Alagar Yadav
Medical Oncology (2023) Vol. 40, Iss. 8
Closed Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

Recent advances in targeted strategies for triple-negative breast cancer
Shuangli Zhu, Yuze Wu, Bin Song, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 112
Development of a versatile biomaterial of chitosan polymer/ginger (Zingiber officinale Roscoe) extract/ZnO bionanocomposite: physicochemical properties, antioxidant activity, and breast cancer therapy
Muthanna O. Hussein, Ahmed Saud Abdulhameed
Research on Chemical Intermediates (2025)
Closed Access | Times Cited: 1
Quercetin exerts anti-tumor immune mechanism by regulating IL-6/JAK2/STAT3 signaling pathway to deplete Treg cells
Yu‐Pei Liao, Xiaoqing Xie, Chu Zhang, et al.
Toxicon (2024) Vol. 243, pp. 107747-107747
Closed Access | Times Cited: 7
Predicting breast cancer recurrence using deep learning
Deepa Kumari, M. Naidu, Subhrakanta Panda, et al.
Deleted Journal (2025) Vol. 7, Iss. 2
Open Access
Emerging phytochemical-based nanocarriers: redefining the perspectives of breast cancer therapy
Gulshan Sharma, Rohil Panwar, Sangeeta Saini, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Paclitaxel Resistance in Breast Cancer: Current Challenges and Recent Advanced Therapeutic Strategies
Heidi A Abouzeid, Loay Kassem, Xumei Liu, et al.
Cancer Treatment and Research Communications (2025), pp. 100918-100918
Open Access
Combining KPNA2 and FOXM1 Expression as Prognostic Markers and Therapeutic Targets in Hormone Receptor-Positive, HER2-Negative Breast Cancer
Tsen‐Long Yang, Chung‐Hsin Tsai, Ying‐Wen Su, et al.
Cancers (2025) Vol. 17, Iss. 4, pp. 671-671
Open Access
Computational Exploration of Multitarget Effects of Curcumin in Breast Cancer Treatment
Shipra Reddy Bethi, Rahul Shirole, Gauri Ghangale, et al.
Pharmaceutical Fronts (2025)
Open Access
Clinical Correlation of Transcription Factor SOX3 in Cancer: Unveiling Its Role in Tumorigenesis
Helen L. Del Puerto, Ana Paula G. S. Miranda, Dinah Qutob, et al.
Genes (2024) Vol. 15, Iss. 6, pp. 777-777
Open Access | Times Cited: 3
Broccoli Cultivated with Deep Sea Water Mineral Fertilizer Enhances Anti-Cancer and Anti-Inflammatory Effects of AOM/DSS-Induced Colorectal Cancer in C57BL/6N Mice
Yeon-Jun Lee, Yanni Pan, Daewoo Lim, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1650-1650
Open Access | Times Cited: 2
Prognostic and clinicopathological significance of fibrinogen-to-albumin ratio (FAR) in patients with breast cancer: a meta-analysis
Zhanwei Wang, Xiaqing Shen
World Journal of Surgical Oncology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 2
Repurposing FDA-Approved Anastrozole-based Drugs for Breast Cancer through Drug-Drug Transcriptomic Similarity and Cavity Detection Guided Blind Docking
Tabjez Mujawar, Harshal Tare, Nitin Deshmukh, et al.
International Journal of Drug Delivery Technology (2023) Vol. 13, Iss. 04, pp. 1172-1177
Open Access | Times Cited: 4
Association of MT1A rs11640851, rs8052394 and rs11076161 polymorphisms with the risk of developing breast cancer: a haplotype-based case-control study and in silico analysis
Maryam Shirvani, Arshia Yadollahi, Zahra Zamanzadeh, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 1
Clinical Correlation of Transcription Factor SOX3 in Cancer: Unveiling Its Role in Tumorigenesis
Helen L. Del Puerto, Ana Paula G.S. Miranda, Dinah Qutob, et al.
(2024)
Open Access | Times Cited: 1
Axillary lymph node removal in de novo metastatic breast cancer
Yalin Wu, Yiyan Hong, Hongliang Zhan, et al.
Gland Surgery (2024) Vol. 13, Iss. 7, pp. 1214-1228
Open Access | Times Cited: 1
A New Mixture Model With Cure Rate Applied to Breast Cancer Data
Diego I. Gallardo, Márcia Brandão, Jeremias Leão, et al.
Biometrical Journal (2024) Vol. 66, Iss. 6
Closed Access | Times Cited: 1
PANoptosis-related molecular clustering and prognostic signature associated with the immune landscape and therapy response in breast cancer
Yiming Cao, LinJing Guan, Li Yang, et al.
Medicine (2024) Vol. 103, Iss. 37, pp. e39511-e39511
Open Access | Times Cited: 1
Preliminary Metabolomics Study Suggests Favorable Metabolic Changes in the Plasma of Breast Cancer Patients after Surgery and Adjuvant Treatment
Andrea Jiménez-Franco, Juan Manuel Jiménez-Aguilar, Marta Canela-Capdevila, et al.
Biomedicines (2024) Vol. 12, Iss. 10, pp. 2196-2196
Open Access | Times Cited: 1
Emerging role of microRNAs as regulators of protein kinase C substrate MARCKS and MARCKSL1 in cancer
Vikas Yadav, Manoj Kumar Jena, Gaurav Parashar, et al.
Experimental Cell Research (2023) Vol. 434, Iss. 2, pp. 113891-113891
Closed Access | Times Cited: 3
Meta-analysis and network pharmacology-based investigation of Shenqi Fuzheng injection plus docetaxel for the efficacy and molecular mechanism of breast cancer
Yanqiong Luo, Yujiao Hou, Qian Li, et al.
European Journal of Integrative Medicine (2024) Vol. 67, pp. 102351-102351
Closed Access
Oncotype DX in Breast Cancer Management: Insights and Outcomes From the United Arab Emirates
Mouza Al Ameri, Nandan M Shanbhag, Abdulrahman Bin Sumaida, et al.
Cureus (2024)
Open Access
Metabolomics Reveals Favorable Metabolic Changes in the Plasma of Breast Cancer Patients after Surgery and Adjuvant Treatment
Andrea Jiménez-Franco, Juan Manuel Jiménez-Aguilar, Marta Canela-Capdevila, et al.
(2024)
Closed Access
Synthesis of 2,2-dimethyl-chroman-based stereochemically flexible and constrained anti-breast cancer agents
Kripa Shanker Nainawat, Kratika Gupta, Neelam Gupta, et al.
Bioorganic & Medicinal Chemistry Letters (2024) Vol. 108, pp. 129789-129789
Closed Access
Histogram analysis of intravoxel incoherent motion imaging: Correlation with molecular prognostic factors and combined subtypes of breast cancer
Dan Yang, Yike Ren, Chunhong Wang
Magnetic Resonance Imaging (2024) Vol. 111, pp. 210-216
Closed Access
Bibliometric analysis of global research trends between gut microbiota and breast cancer: from 2013 to 2023
Xianguang Deng, Hua Yang, Lingjia Tian, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access
Page 1 - Next Page

Scroll to top